Are we still in a golden age for biotech investing? Join the discussion at noon.
admin Are we still in a golden age for biotech investing? Join the discussion at noon.
Read Morewebinar platform
Webinar: Jan. 9: MarketWatch – Best Timing for I Bonds by Barron’s Events
David Enna David Enna is a long-time journalist based in Charlotte, N.C. A past recipient…
Read MoreWebinar: Jan. 4: MarketWatch – Where’s The Real Estate Market Going To Go In 2023? by Barron’s Events
Glenn Kelman CEO, Redfin Glenn is the CEO of Redfin. Prior to joining Redfin, he…
Read MoreWebinar: Dec. 21: MarketWatch – Charge Up Your Portfolio: Best Bets in Payments for 2023 by Barron’s Events
Lisa Ellis Senior Managing Director, MoffettNathanson Lisa Ellis is a Senior Research Analyst at MoffettNathanson,…
Read MoreWebinar: Dec. 14: MarketWatch – The Best Fund Manager You’ve Never Heard Of by Barron’s Events
Steve Russell Investment Director, Ruffer Graduated from the University of Oxford in philosophy, politics and…
Read MoreThe Darker Side of Money — This Year in Fraud by Barron’s Events
Lukas I. Alpert Financial Investigations Reporter, MarketWatch Lukas I. Alpert covers financial crime for MarketWatch.…
Read MoreWebinar: Nov. 28: St. Louis Fed President James Bullard
James Bullard President and CEO, Federal Reserve Bank of St. Louis James (“Jim”) Bullard is…
Read MoreMarketWatch – Controversial Qatar World Cup Poses Big Challenges for Corporate Sponsors by Barron’s Events
Jim is an acknowledged expert in the fields of sponsorship, event and sports marketing. He…
Read MoreWebinar: Nov. 16: MarketWatch – Financial Face-off by Barron’s Events
Andrew Keshner Personal Finance Reporter, MarketWatch Andrew Keshner is a reporter at MarketWatch, where he…
Read MoreWatch: What a top policy researcher will be watching as election returns roll in
Watch: What a top policy researcher will be watching as election returns roll in
Read More